Search results for: EFPIA
Filter search results
Summary Report of the OHE/EFPIA Antibacterial Roundtable
1 November 2011
Antibacterial drug resistance is a serious and growing worldwide problem that threatens our ability to cure traditionally treatable diseases and to successfully perform numerous surgical procedures that rely on antibacterials….
Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?
12 April 2024
…European Commission and EFPIA proposals. [online] Available at: https://www.efpia.eu/media/msadqxbf/revision-of-the-general-pharmaceutical-legislation-gpl-impact-assessment.pdf [Accessed 5 Apr. 2024]. Dubois, P., de Mouzon, O., Scott-Morton, F. and Seabright, P., 2015. Market size and pharmaceutical innovation. The RAND Journal…
Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe
1 October 2010
Ten member companies of the EFPIA HTA Task Force commissioned OHE consulting to provide research, data and analysis that would enable EFPIA both to support and develop its policy position…
Thomas Allvin
19 March 2024
…EFPIA Board and Executive Committee and leading EFPIA’s work on policies for more sustainable, value-based and patient-centric health systems, including patient and stakeholder relations. Before joining EFPIA in 2015, Thomas…
Delivering the Triple Win: A Value-Based Approach to Pricing
20 April 2023
…pipeline. This is why EFPIA is working with governments and stakeholders to identify and promote pricing approaches that deliver a ‘triple win’: ensure medicines are accessible, the healthcare system is…
Breaking the European Deadlock: Part 2 – Transferable Exclusivity Vouchers – Effective Pull Incentive or a Policy Distraction?
4 January 2024
…Wilsdon et al. (2022). A framework for assessing the potential net benefits realised through Transferable Exclusivity Extension (TEE) as an incentive for development of novel antimicrobials: FINAL REPORT. Available at: https://www.efpia.eu/media/676634/cra-efpia-a-framework-for-assessing-the-costs-and-benefits-of-tee-final-report.pdf…
Antibacterials: Roundtable Addresses the Critical Issues
10 November 2011
…a positive effect, and (5) the pharmaceuticals industry’s openness to new approaches that separate financial returns from volume of sales represents a historic opportunity. In the afternoon, EFPIA sponsored a…
Richard Torbett
3 February 2023
…the last 14 years working in the pharmaceutical industry. Immediately prior to joining ABPI he was the Chief Economist at the European Federation of Pharmaceutical Industries and Associations (EFPIA) where…
Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation
1 December 2018
…are poorly understood, particularly in relation to the new General Data Protection Regulation (GDPR). In this consulting report, sponsored by the European Federation of Pharmaceutical Industries and Associations (EFPIA), we…